Anonymised Delhi NCR Hospital Group — Healthcare Growth Transformation

Client profile: Multi-hospital group · 4 hospitals · 580 combined beds · Delhi NCR · ₹185 crore annual revenue · CMO tenure 14 months at engagement start · board-level pressure on marketing ROI for 2 quarters prior to engagement.

The problem as it presented

The CMO walked into her first board meeting with a slide showing ₹3.2 crore in marketing spend and 8,400 total leads. The CFO asked one question: "What did that generate in revenue?"

She could not answer.

Not because the revenue wasn't there. It was — the group was generating approximately ₹185 crore annually across four hospitals, with new patient consultations running at 3,200–3,800 per month. The problem was that the marketing system and the revenue system had never been connected. Marketing ran Google Ads and Meta Ads and tracked leads in a spreadsheet. Patient coordination booked consultations and tracked attendance in a different spreadsheet. Finance reported revenue by department. Three systems. Three numbers. No connection between any of them.

When the board asked "what did marketing generate?", the honest answer was: we do not know.

What the Growth Diagnostic revealed

ICG's Phase 1 diagnostic (weeks 1–4) revealed four specific findings:

Finding 1 — The real CPQL was 2.4× the reported CPL. The group was reporting a blended CPL of ₹840 across all hospitals and all specialties. When ICG mapped every lead to consultation attendance at the specialty level — using manual audit of 4,600 lead records across 12 months — the real blended CPQL was ₹2,400. Cardiology OPD: ₹3,100. Orthopaedics: ₹2,600. Gynaecology: ₹1,900.

The gap existed for one reason: the group was measuring enquiries, not consultations. An enquiry that generated no consultation was still counted. No-shows, duplicate enquiries, low-intent WhatsApp messages — all counted equally in the CPL calculation. The actual cost of generating a patient who sat in front of a doctor was invisible.

Finding 2 — 53% of consultation revenue was unattributed to any marketing source. Only 47% of the group's 3,400+ monthly new-patient consultations could be connected to a marketing touchpoint. The other 53% came from sources that existed — GP referrals, walk-ins, word-of-mouth, hospital website organic traffic — but had never been systematically captured or attributed.

This meant the marketing P&L the CMO could produce showed only 47% of the actual marketing contribution to revenue. The other 53% — worth approximately ₹40–50 crore in annual revenue attribution — was invisible at board level.

Finding 3 — The technology stack was running on 2021 infrastructure in 2026. All four hospitals were using standard pixel-based Google Tag Manager tracking. No server-side CAPI. No Enhanced Conversions. In 2026, iOS 17's Link Tracking Protection and Safari ITP were degrading Meta pixel conversion capture by an estimated 35–42% across the account. In practical terms: approximately 38% of all Meta conversions were invisible to the Smart Bidding algorithm. The algorithm was optimising on a biased sample of actual conversions — systematically under-valuing high-converting audience segments that iOS users disproportionately represented.

Finding 4 — 31% of monthly leads were in "limbo" at day 30. Of the 8,400 monthly leads the group was generating, 2,604 were sitting unresponded-to at the 30-day mark — contacted once, no response, then abandoned by the patient coordination system. In a 30–90 day consideration cycle for most of the group's specialties, these were not lost patients. They were patients who had not yet decided.

The intervention

ICG engaged across all four hospitals simultaneously with the following architecture:

Beacon CAPI deployment (weeks 9–12): Server-side conversion tracking replacing pixel-only attribution. Meta EMQ moved from 4.1 to 7.9 within 6 weeks of deployment. Google Enhanced Conversions active for all specialty campaigns. Attribution window configured per specialty: 14 days for gynaecology OPD, 45 days for orthopaedics, 90 days for cardiology elective.

Agency OS configuration (weeks 11–14): Unified CPQL dashboard across all four hospitals. CPQL by specialty (8 active specialties), CPQL by channel (Google vs Meta vs organic vs GP referral), CPQL by hospital. The first unified board-ready report generated at the end of week 16.

Hawk deployment (weeks 13–16): Automated 90-day re-engagement sequences for limbo leads. Four-touchpoint sequence (day 7, day 21, day 45, day 75) across WhatsApp for all four hospitals. Within the first 30 days of Hawk activation: 19% of limbo leads rebooked consultations across the group — equivalent to 495 consultations at zero additional media spend.

Specialty-by-specialty campaign architecture (weeks 9–16): Separate Google Ads campaigns per specialty per hospital. Procedure-specific landing pages (replacing the group's default practice of sending all ad traffic to the hospital homepage). Archetype-specific Meta creative briefs per specialty.

Fractional CGO engagement: Rohit Gupta engaged as Fractional CGO from month 3, attending quarterly board meetings and presenting the monthly Agency OS intelligence report at the board-level format.

Outcomes at 90 days, 180 days, and 365 days

90-day outcomes:

• Agency OS unified dashboard live across all 4 hospitals
• Real CPQL baseline: ₹2,400 (from reported ₹840 CPL)
• Hawk first-cycle recovery: 19% of limbo leads rebooked (495 consultations, ₹0 incremental media spend)
• Meta EMQ: 4.1 → 7.9 across group accounts
• Attribution rate: 47% → 59% (first clean P&L produced at week 16)

180-day outcomes:

• Blended CPQL: ₹2,400 → ₹1,900 (21% reduction; algorithm learning from CAPI data)
• Attribution rate: 59% → 68%
• First YouTube organic consultations attributed via YODA (7/month, primarily cardiology)
• Hawk recovery rate stabilised: 22% of monthly limbo leads rebooking
• First Fractional CGO board presentation delivered: marketing P&L with 68% attributed revenue

365-day outcomes:

• Blended CPQL: ₹1,850 — 23% below market median for the group's specialty mix
• Attribution rate: 79% — 79% of new-patient consultation revenue now attributable to a specific marketing touchpoint
• MRR:CAC ratio: 3.2× → 8.4× (from first calculating this number to 12 months later)
• Organic consultation share: 8% → 24% (SEO compound beginning)
• YouTube programme: 18 organic consultations/month (cardiology + orthopaedics YODA programme)
• Hawk: 22% recovery rate across group, representing 580+ additional consultations per month at ₹0 incremental media spend

What the CFO told the board at month 18

"For the first time, I can defend marketing spend line-by-line at board level. Before ICG, we had a ₹3.2 crore marketing line and no defensible narrative for what it generated. Now I have a dashboard showing ₹1,850 CPQL by specialty, 79% revenue attribution, and a specific month-on-month improvement trend. The marketing investment is now a business investment with a measurable return."

(Paraphrased, anonymised. Direct quotation held in ICG client records.)

Which ICG products powered the transformation

• Beacon CAPI — server-side attribution, Meta EMQ improvement, Google Enhanced Conversions, 180-day attribution window configuration
• Agency OS — unified CPQL dashboard across 4 hospitals, 8 specialties, 4 channels; monthly Gemini-powered board narrative
• Hawk — 90-day limbo lead re-engagement; 22% monthly recovery rate
• YODA — YouTube content research and attribution; 18 organic consultations/month by month 12
• Fractional CGO engagement — Rohit Gupta as strategic growth lead; quarterly board presentations; monthly strategic sessions with CMO and CFO

NMC S6 + DPDP Act 2023 compliant. Client details anonymised. ICG holds client consent for case study publication. Individual results vary based on specialty mix, city, competitive landscape, and programme maturity.